Novavax Stock Tanks After FDA’s Clinical Hold On Vaccine Candidates: Retail Turns Jittery

The clinical hold was triggered by a report of a serious adverse event (SAE) involving motor neuropathy in a participant from a CIC Phase 2 trial conducted outside the U.S.